In Memoriam

鄭添祿06
Professor Tian-Lu Cheng dedicated 25 years to antibody engineering and invented Universal Antibody Lock. He served as the Chief Scientific Officer at PrecisemAb and was widely recognized as an authority in antibody research and development in Taiwan.
During his career, he acquired 18 international patents and completed 135 technology transfers, generating over 300 million NT dollars in royalties.

Founder

Tian-Lu Cheng

1967 – 2024
Chair Professor / Chief Scientific Officer

Career and Contributions

2024
Vice Chancellor, Kaohsiung Medical University
2018 – 2024
Chair Professor, Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University
2018 – 2021
Provost, Office of Research and Development, Kaohsiung Medical University
2015 – 2018
Associate Dean, College of Medicine, Kaohsiung Medical University

In Memory and Tribute

Professor Tian-Lu Cheng made extraordinary contributions to antibody drug research and precision medicine, laying the foundation of PrecisemAb’s technological innovation.Although he has left us, his vision for innovation, scientific spirit, and commitment to human health will continue to inspire us on our journey forward.We deeply mourn his passing and pay our highest respect and heartfelt tribute to his legacy.